跳至主要内容
临床试验/NL-OMON56087
NL-OMON56087招募中不适用

Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a standardized surveillance strategy - an international randomized controlled trial by the Dutch Pancreatic Cancer Group - RADAR-PANC

niversitair Medisch Centrum Utrecht0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Histologically confirmed macroscopically radical resected (R0-R1) pancreatic
  • adenocarcinoma
  • - Age >= 18 years
  • - Written informed consent for being randomized in future studies

排除标准

  • - Exclusion criteria for contrast-enhanced CT scan, following the protocol of
  • the department of radiology in each DPCG affiliated hospital
  • - Mentally or physically incapable of consent
  • - Participation in other DPCG studies with a study-specific follow-up

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验